Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on April 14, 2025
Music Worcester Names Conductor and Educator Everett McCorvey 2026 Artist in Residence
EIN Presswire
·
April 14, 2025
Noted Tenor, Conductor, Impresario …
Recognize a Financial Educator Who Made a Difference
EIN Presswire
·
April 14, 2025
BOSTON, MA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The Massachusetts Financial Educators Council (MFEC) Advisory Board, led by founding member Ellis Cropper, invites nominations for this year’s Financial Educators Day Awards. These awards …
Censinet, KLAS, and American Hospital Association Publish the 2025 Healthcare Cybersecurity Benchmarking Study
EIN Presswire
·
April 14, 2025
Co-Led by Censinet, KLAS, AHA, Health-ISAC, HSCC, and The Scottsdale Institute, 2025 Benchmarking Study Details State of Healthcare Cyber Maturity, Preparedness BOSTON, MA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Censinet, the leading …
Medical professionals, Doctors, Nurses and others increasingly search for improved health insurance options 2025
EIN Presswire
·
April 14, 2025
Medical professionals now search for new solutions due to changes in health policy and increased premiums combined with employer benefit reductions. BOSTON, MA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Small Business Health Insurance in …
Creatio Recognized as a Strong Performer in CRM Software For Financial Services Report, Q1 2025
EIN Presswire
·
April 14, 2025
The report evaluates the 7 top CRM providers for financial services with Creatio recognized for its vision to unify AI, no-code, and vertical CRM BOSTON, MA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Creatio, a global vendor of an AI-native …
Cue Biopharma Announces Proposed Public Offering
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Cue Biopharma to Host Business Update Call and Webcast
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Medicinal Genomics Earns AOAC Certification for Next Generation PathoSEEK® Platform
EIN Presswire
·
April 14, 2025
New Salmonella …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 14, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …
Stran & Company Reports Financial Results for 2024 Fiscal Year
GlobeNewswire
·
April 14, 2025
- 2023/2022 Financial Statements Re-audit Completed; Refocusing on Growth and Operational Initiatives - - Sales Increased 8.8% to $82.7 Million - - Conference Call Scheduled for Tuesday, April 15 at 11:00 A.M. ET - QUINCY, Mass., April 14, 2025 (GLOBE …
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 14, 2025
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …
Create Jeopardy games in minutes using AI with Factile’s AutoGen
EIN Presswire
·
April 14, 2025
Factile’s new feature, “AutoGen" allows users to save time and effort by generating questions and answers for their Jeopardy games using AI. BOSTON, MA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Factile, the leading Jeopardy game maker with …
BBAI Investor ALERT: BigBear.ai Holdings, Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Block …
DRML Miner Launches New Opportunities for Cryptocurrency Newbies
GlobeNewswire
·
April 14, 2025
Middlesex, UK, April 14, 2025 (GLOBE NEWSWIRE) -- As times change, people's attitudes towards energy have also changed. They rely on renewable energy sources such as solar and wind power to power their new energy cloud mining operations, which greatly …
Tier One Partners Named to PRovoke Media’s List of 80 Best PR Agencies in the US
GlobeNewswire
·
April 14, 2025
BOSTON and CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Tier One Partners, a women-owned, full-service integrated marketing agency, today announced its inclusion in PRovoke Media’s inaugural list of the 80 Best PR Agencies in the United States. This highly …
MedTech Industry Leader Jeffrey Goble Appointed to ThermoFab’s Advisory Board
GlobeNewswire
·
April 14, 2025
SHIRLEY, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- ThermoFab (the “Company” or “ThermoFab”), a trusted leader in thermoforming and injection molding heavy gauge plastic enclosures and single use components for medical device and other critical highly …
Liberty Defense Garners Another Sale of the HEXWAVE Unit & Another New Channel Sales Partner for the Country of Brazil & Launching of a Significant Capital Markets Investor Awareness Campaign
GlobeNewswire
·
April 14, 2025
WILMINGTON, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: FSE:E30), a leading technology provider of Artificial Intelligence (AI) based next generation detection …
Flywire to Announce First Quarter 2025 Results on May 6, 2025
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its first quarter financial results will be released after market close on Tuesday, May 6, …
MKS Instruments Announces First Quarter 2025 Earnings Conference Call
GlobeNewswire
·
April 14, 2025
ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market …
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
GlobeNewswire
·
April 14, 2025
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-102 was well-tolerated with no treatment-related serious …